EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Expert Consensus. Role of combination lipid-lowering therapy (simvastatin/ezetimibe 20/10 mg) in the correction of lipid metabolism disturbances in patients with chronic kidney disease.
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2013-08-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/217 |
| _version_ | 1827063876002250752 |
|---|---|
| author | A. Catapano E. V. Shlyakhto A. I. Martynov R. G. Oganov V. V. Kukharchuk M. V. Shestakova A. S. Ametov S. A. Boicov M. G. Bubnova S. V. Villevalde A. S. Galyavich Yu. A. Karpov J. D. Kobalava O. N. Koziolova |
| author_facet | A. Catapano E. V. Shlyakhto A. I. Martynov R. G. Oganov V. V. Kukharchuk M. V. Shestakova A. S. Ametov S. A. Boicov M. G. Bubnova S. V. Villevalde A. S. Galyavich Yu. A. Karpov J. D. Kobalava O. N. Koziolova |
| author_sort | A. Catapano |
| collection | DOAJ |
| description | Expert Consensus. Role of combination lipid-lowering therapy (simvastatin/ezetimibe 20/10 mg) in the correction of lipid metabolism disturbances in patients with chronic kidney disease. |
| first_indexed | 2024-04-10T03:36:57Z |
| format | Article |
| id | doaj.art-16dc7004b2a04aecb190a64ca269eadf |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2025-03-19T22:38:12Z |
| publishDate | 2013-08-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-16dc7004b2a04aecb190a64ca269eadf2024-10-17T12:21:32Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252013-08-01124757810.15829/1728-8800-2013-4-75-78217EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASEA. Catapano0E. V. Shlyakhto1A. I. Martynov2R. G. Oganov3V. V. KukharchukM. V. ShestakovaA. S. AmetovS. A. BoicovM. G. BubnovaS. V. VillevaldeA. S. GalyavichYu. A. KarpovJ. D. KobalavaO. N. KoziolovaПрезидент Европейского общества атеросклерозаПрезидент РКОПрезидент РНМОТакад. РАМН В.С. МоисеевExpert Consensus. Role of combination lipid-lowering therapy (simvastatin/ezetimibe 20/10 mg) in the correction of lipid metabolism disturbances in patients with chronic kidney disease.https://cardiovascular.elpub.ru/jour/article/view/217 |
| spellingShingle | A. Catapano E. V. Shlyakhto A. I. Martynov R. G. Oganov V. V. Kukharchuk M. V. Shestakova A. S. Ametov S. A. Boicov M. G. Bubnova S. V. Villevalde A. S. Galyavich Yu. A. Karpov J. D. Kobalava O. N. Koziolova EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE Кардиоваскулярная терапия и профилактика |
| title | EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE |
| title_full | EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE |
| title_fullStr | EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE |
| title_full_unstemmed | EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE |
| title_short | EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DISEASE |
| title_sort | expert consensus role of combination lipid lowering therapy simvastatin ezetimibe 20 10 mg in the correction of lipid metabolism disturbances in patients with chronic kidney disease |
| url | https://cardiovascular.elpub.ru/jour/article/view/217 |
| work_keys_str_mv | AT acatapano expertconsensusroleofcombinationlipidloweringtherapysimvastatinezetimibe2010mginthecorrectionoflipidmetabolismdisturbancesinpatientswithchronickidneydisease AT evshlyakhto expertconsensusroleofcombinationlipidloweringtherapysimvastatinezetimibe2010mginthecorrectionoflipidmetabolismdisturbancesinpatientswithchronickidneydisease AT aimartynov expertconsensusroleofcombinationlipidloweringtherapysimvastatinezetimibe2010mginthecorrectionoflipidmetabolismdisturbancesinpatientswithchronickidneydisease AT rgoganov expertconsensusroleofcombinationlipidloweringtherapysimvastatinezetimibe2010mginthecorrectionoflipidmetabolismdisturbancesinpatientswithchronickidneydisease AT vvkukharchuk expertconsensusroleofcombinationlipidloweringtherapysimvastatinezetimibe2010mginthecorrectionoflipidmetabolismdisturbancesinpatientswithchronickidneydisease AT mvshestakova expertconsensusroleofcombinationlipidloweringtherapysimvastatinezetimibe2010mginthecorrectionoflipidmetabolismdisturbancesinpatientswithchronickidneydisease AT asametov expertconsensusroleofcombinationlipidloweringtherapysimvastatinezetimibe2010mginthecorrectionoflipidmetabolismdisturbancesinpatientswithchronickidneydisease AT saboicov expertconsensusroleofcombinationlipidloweringtherapysimvastatinezetimibe2010mginthecorrectionoflipidmetabolismdisturbancesinpatientswithchronickidneydisease AT mgbubnova expertconsensusroleofcombinationlipidloweringtherapysimvastatinezetimibe2010mginthecorrectionoflipidmetabolismdisturbancesinpatientswithchronickidneydisease AT svvillevalde expertconsensusroleofcombinationlipidloweringtherapysimvastatinezetimibe2010mginthecorrectionoflipidmetabolismdisturbancesinpatientswithchronickidneydisease AT asgalyavich expertconsensusroleofcombinationlipidloweringtherapysimvastatinezetimibe2010mginthecorrectionoflipidmetabolismdisturbancesinpatientswithchronickidneydisease AT yuakarpov expertconsensusroleofcombinationlipidloweringtherapysimvastatinezetimibe2010mginthecorrectionoflipidmetabolismdisturbancesinpatientswithchronickidneydisease AT jdkobalava expertconsensusroleofcombinationlipidloweringtherapysimvastatinezetimibe2010mginthecorrectionoflipidmetabolismdisturbancesinpatientswithchronickidneydisease AT onkoziolova expertconsensusroleofcombinationlipidloweringtherapysimvastatinezetimibe2010mginthecorrectionoflipidmetabolismdisturbancesinpatientswithchronickidneydisease |